99mTc-TRODAT-1, as a tropane-derived compound with highly selective binding to the dopamine transporter, has been extensively used as an in vivo biomarker to evaluate parkinsonism. There have been few reports indicating various etiologies about extrastriatal findings on the 99mTc-TRODAT-1 SPECT. We herein present an interesting case about the incidental discovery of brain lymphoma with increasing uptake of 99mTc-TRODAT-1.
From the *Department of Nuclear Medicine and PET Center Hospital, China Medical University Hospital
†Department of Biomedical Imaging and Radiological Science
‡School of Medicine, China Medical University
§Department of Nuclear Medicine, Lin Shin Hospital, Taichung City
∥Department of Nuclear Medicine, National Taiwan University Hospital
¶School of Medicine, National Taiwan University, Taipei City, Taiwan.
Received for publication March 6, 2019; revision accepted March 21, 2019.
Conflicts of interest and sources of funding: none declared.
Y.-C.W. and T.-C.H. contributed equally to this work.
Correspondence to: Te-Chun Hsieh, MD, Department of Nuclear Medicine and PET Center, China Medical University Hospital, China Medical University, No. 2, Yuh-Der Rd, North District, 40402, Taichung City, Taiwan. E-mail: email@example.com.
Online date: May 3, 2019